Background: Septic arthritis (SA) in the neonatal period is rare but important clinical condition that needs timely recognition, and treatment to save the joint and life of the baby. The objective of this study was to look at the clinical profile of babies presenting with septic arthritis in neonatal period.
Materials and Methods: This was a prospective observational study from 2019 to 2020 undertaken in SNCU.
Results: There were 13 babies who met the criteria of SA and data was collected after obtaining consent. All of them were born at term, mostly males (n=12). The mean age at presentation was day 17 (10-28days), after a mean duration of 3 days from the onset of symptoms. It was monoarticular in 11 babies. The most common joint that got involved was knee. Methicillin Resistant Staphylococcal aureus (MRSA) was the most common isolate from blood and joints. All the babies received a minimum of 3 weeks parenteral antibiotics.
Conclusion: The diagnosis of SA is mostly done clinically. With the advent of MRSA, it is important to include Vancomycin/Linezolid for the recommended duration.
Septic arthritis (SA), Neonatal, Methicillin Resistant Staphylococcal Aureus (MRSA).